Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Prajakta Jogdand (Lund, Sweden), Prajakta Jogdand, Michiko Mori, Anders Bergqvist, Andrew Walls, Caroline Sanden, Jonas Erjefält. Mapping of eosinophil and basophils in COPD lung tissues. Eur Respir J 2015; 46: Suppl. 59, 384

Member's Comments

No comment yet.

Related content which might interest you: Distribution of blood eosinophil in COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Expression of HLA-DR in circulating polymorphonuclear neutrophils of COPD patients Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Elevated IL-17A in very severe COPD is localized to mast cells and correlates with lung function decline Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 ADAM9 is upregulated in human COPD lungs and in human and murine lung in response to cigarette smoke Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Neutrophil numbers are decreased in bronchial biopsies from patients with COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 M2 macrophage marker CD163, CD204 and CD206 expression on alveolar macrophages in the lung of patients with chronic obstructive pulmonary Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients Source: International Congress 2014 – Translational studies in COPD Year: 2014 Blood eosinophils and outcomes in COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Peripheral blood eosinophilia predicts lower airway eosinophilia in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Alterations of the soluble proteome of airway epithelial cells in COPD Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Modulation of inflammation by benralizumab in eosinophilic airway disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 The role of chemokine receptors in the aberrant migration of COPD neutrophils Source: International Congress 2014 – Cell biology 2014 Year: 2014 Can blood eosinophils predict sputum eosinophils in stable COPD? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 TNFalpha release by monocyte-derived macrophages at stable and exacerbation states in COPD Source: International Congress 2014 – COPD physiopathology Year: 2014 Lung function decline in COPD in relation to MMP-12 and surfactant protein A Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Soluble FasL and Fas+ lymphocytes in peripheral blood of non-smoking patients with COPD Source: International Congress 2014 – Translational studies in COPD Year: 2014 Macrophage migration inhibition factor in peripheral blood and induced sputum in patients with COPD Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014 Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015